2018

1. Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy

   Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii476